Trial intelligence / Profile preview

Maxigesic oral suspension dosing study for post-tonsillectomy pain in children

ACTRN12615000456550Phase 3Completed

Sponsor
AFT Pharmaceuticals
Start
Sep 2015
Modality
Small Molecules
Countries
2
01

Overview

Phase 3 trial of acetaminophen + ibuprofen, acetaminophen and ibuprofen in postoperative pain (2 arms), sponsored by AFT Pharmaceuticals. Primary endpoints: Pharmacokinetic profile of two dose regimens of Maxigesic oral suspension and Pain on swallowing on postoperative day 1. Started Sep 2015; status: completed.

02

Drugs

acetaminophen + ibuprofenacetaminophenibuprofen
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ACTRN12615000456550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12615000456550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call